Tasimelteon 50 mg | Purity Not Available
TargetMol
Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals.
More Information Supplier PageTasimelteon
Search Results
Tasimelteon 10 mg | Purity Not Available
TargetMol
Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals.
More Information Supplier PageTasimelteon
Tasimelteon 100 mg | Purity Not Available
TargetMol
Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals.
More Information Supplier PageTasimelteon
Secoisolariciresinol diglucoside 25 mg | 100.00%
TargetMol
Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol Diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
More Information Supplier PageSecoisolariciresinol diglucoside
Secoisolariciresinol diglucoside 10 mg | 100.00%
TargetMol
Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol Diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
More Information Supplier PageSecoisolariciresinol diglucoside
Secoisolariciresinol diglucoside 100 mg | 100.00%
TargetMol
Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol Diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
More Information Supplier PageSecoisolariciresinol diglucoside
Hydroxytyrosol 25 mg | 100.00%
TargetMol
Hydroxytyrosol (2-(3,4-Di-hydroxyphenyl)-ethanol) is an active ingredient extracted from the olive. It is one of the most efficient and secure antioxidants and can be used in the cardiovascular drugs.
More Information Supplier PageHydroxytyrosol
Hydroxytyrosol 10 mg | 100.00%
TargetMol
Hydroxytyrosol (2-(3,4-Di-hydroxyphenyl)-ethanol) is an active ingredient extracted from the olive. It is one of the most efficient and secure antioxidants and can be used in the cardiovascular drugs.
More Information Supplier PageHydroxytyrosol
Hydroxytyrosol 100 mg | 100.00%
TargetMol
Hydroxytyrosol (2-(3,4-Di-hydroxyphenyl)-ethanol) is an active ingredient extracted from the olive. It is one of the most efficient and secure antioxidants and can be used in the cardiovascular drugs.
More Information Supplier PageHydroxytyrosol
Secoisolariciresinol diglucoside 50 mg | 100.00%
TargetMol
Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol Diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
More Information Supplier PageSecoisolariciresinol diglucoside